Assignee
GI CELL INC
KR·4 granted patents·8 pending applications·4 citations·filing 2019–2023
Top patents by PatentIndex Score
12 records- 0187US11702633B2Composition for culturing regulatory T cells and use thereofGI CELL INC·Filed 2022·Granted Jul 18, 2023·4 cites·6 claims
- 0265US2023407253A1Composition for culturing regulatory t cells and use thereofGI CELL INC·Filed 2023·Application pending·0 cites
- 0361US2024277787A1Use of lactobacillus fermentum strain and natural killer cells for combination therapy for prevention or treatment of metabolic diseasesGI CELL INC·Filed 2022·Application pending·0 cites
- 0461US2024269202A1Use of lactobacillus fermentum strain and regulatory t cells for combination therapy for prevention or treatment of metabolic diseasesGI CELL INC·Filed 2022·Application pending·0 cites
- 0560US2024237635A1Composition for nk cell cryopreservation and cryopreservation formulation comprising sameGI CELL INC·Filed 2022·Application pending·0 cites
- 0656US2024082387A1Fusion protein comprising coronavirus-derived receptor-binding domain and nucleocapsid protein, and use thereofGI CELL INC·Filed 2021·Application pending·0 cites
- 0755US2023355745A1Coronavirus-derived receptor-binding domain variant having reduced ace2-binding affinity and vaccine composition comprising the sameGI CELL INC·Filed 2021·Application pending·0 cites
- 0853US12115261B2Block copolymer comprising hydrophilic first block, hydrophobic second block, and functional group capable of specifically binding to thiolGI CELL INC·Filed 2019·Granted Oct 15, 2024·0 cites·18 claims
- 0949US12378526B2Composition for culturing natural killer cells and method for preparing natural killer cells by using sameGI CELL INC·Filed 2022·Granted Aug 5, 2025·0 cites·10 claims
- 1048US12516290B2Medium composition for culturing T cells and method for culturing T cells using sameGI CELL INC·Filed 2020·Granted Jan 6, 2026·0 cites·9 claims
- 1143US2023322881A1Fusion protein including il15 protein, il15 receptor alpha protein, fc domain, and il2 protein, and use thereofGI CELL INC·Filed 2021·Application pending·0 cites
- 1242US2023014358A1Composition for anticancer treatment, comprising nk cells and fusion protein which comprises il-2 protein and cd80 proteinGI CELL INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →